Virus Budding and the ESCRT Pathway  by Votteler, Jörg & Sundquist, Wesley I.
Cell Host & Microbe
ReviewVirus Budding and the ESCRT PathwayJo¨rg Votteler1 and Wesley I. Sundquist1,*
1Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112-5650, USA
*Correspondence: wes@biochem.utah.edu
http://dx.doi.org/10.1016/j.chom.2013.08.012
Enveloped viruses escape infected cells by budding through limitingmembranes. In the decade since the dis-
covery that HIV recruits cellular ESCRT (endosomal sorting complexes required for transport) machinery to
facilitate viral budding, this pathway has emerged as the major escape route for enveloped viruses. In cells,
the ESCRT pathway catalyzes analogous membrane fission events required for the abscission stage of
cytokinesis and for a series of ‘‘reverse topology’’ vesiculation events. Studies of enveloped virus budding
are therefore providing insights into the complex cellular mechanisms of cell division and membrane protein
trafficking (and vice versa). Here, we review how viruses mimic cellular recruiting signals to usurp the ESCRT
pathway, discuss mechanistic models for ESCRT pathway functions, and highlight important research
frontiers.Enveloped Virus Budding
Cell membranes present significant dissemination barriers, and
viruses have therefore developed sophisticated mechanisms
for entering and exiting cells. Here, we review how enveloped
viruses bud through membranes and thereby acquire their lipid
bilayers, with a particular focus on viruses that employ the ubiq-
uitous strategy of usurping the cellular ESCRT (endosomal sort-
ing complexes required for transport) pathway. Although
ESCRT-dependent budding is best studied for retroviruses,
particularly HIV-1, a remarkable variety of enveloped viruses
use this pathway to escape cells (Table S1). Comparative
virology is providing important insights not only into virology,
but also into the cellular functions and mechanisms of the
ESCRT machinery (reviewed in Agromayor and Martin-Serrano,
2013; Hanson and Cashikar, 2012; Henne et al., 2011; Hurley
and Hanson, 2010; McCullough et al., 2013; Weissenhorn
et al., 2013). This approach is particularly powerful because
ESCRT pathways are conserved across Eukarya and are even
found in Archaea; for example, in crenarchaeal hyperthermo-
philes such as Sulfolobus solfataricus, the ESCRT pathway is
used for egress of the enveloped sulfolobus turreted icosahedral
virus (STIV) (Snyder et al., 2013).
Enveloped viruses commonly assemble and bud at the plasma
membrane, although some bud into internal compartments (Lor-
izate and Kra¨usslich, 2011). In the latter cases, the internal
compartment must ultimately fuse with the plasma membrane
to release the virus from the cell. The topology of virus budding
differs from classical cellular vesiculation processes such as
endocytosis, where the membrane constricts away from the
cytoplasm and membrane fission is catalyzed by cytoplasmic
dynamin, which acts from the outside of the bud neck. In
contrast, themembranes of budding virusesmust be constricted
toward the cytoplasm, and cytoplasmic host factors that cata-
lyze membrane fission must work from within the bud neck.
The ESCRT pathway remains the only well-characterized cellular
pathway known to perform such ‘‘reverse topology’’ membrane
fission events, and this capability seems to explain why so many
different viruses have evolved to usurp this machinery.
Conceptually, virus budding can be divided into two stages: (1)
membrane deformation, when the membrane is ‘‘wrapped’’232 Cell Host & Microbe 14, September 11, 2013 ª2013 Elsevier Incaround the assembling virion, and (2) membrane fission, when
the bud neck is severed. The structural proteins of enveloped
viruses typically bind membranes and form spherical or helical
assemblies. Thus, assembly and budding are often inextricably
linked processes. It has generally been assumed that the energy
provided by protein-protein and protein-membrane interactions
is sufficient to drive membrane envelopment, although there
are intriguing hints that cellular factors may sometimes be re-
cruited to help with membrane bending, much as membrane
bending proteins cooperate with clathrin scaffolds to create
endosomal vesicles (McMahon and Boucrot, 2011). The ESCRT
machinery then typically draws the opposing membranes
together and mediates the final membrane fission step required
for virus release.
The different stages of virus budding are nicely illustrated by
the process of HIV-1 assembly (Sundquist and Kra¨usslich,
2012). As in other retroviruses, the HIV-1 Gag polyprotein func-
tions as the major viral structural protein. Gag is targeted to
the inner leaflet of the plasma membrane by a bipartite signal
comprising an N-myristoyl fatty acid modification and a binding
site for the plasma membrane-specific phosphatidyl inositol,
PI(4,5)P2. Gag molecules capture the viral RNA genome and
assemble into a spherical virion that is organized on a semiregu-
lar hexagonal net (Bharat et al., 2012). Recombinant HIV-1 Gag
molecules can form spherical particles in vitro, and Gag assem-
bly can therefore contribute to the energy required formembrane
deformation (Campbell and Rein, 1999). Under some conditions,
however, retroviral assembly can arrest before fully spherical
virions are formed, suggesting that host factors may also partic-
ipate in membrane deformation and Gag assembly (Dooher
et al., 2007; Gottwein et al., 2003; Le Blanc et al., 2002; Zhang
et al., 2011). Assembling HIV-1 Gag molecules also recruit
early-acting factors of the ESCRT pathway required to complete
the membrane fission step. In the absence of ESCRT factor
recruitment, virus assembly typically arrests at a late stage in
which the fully assembled viral Gag shell remains connected to
the plasmamembrane through a thin membrane ‘‘stalk’’ (Go¨ttlin-
ger et al., 1991). Thus, the ESCRT pathway functions primarily to
mediate the membrane fission step required for virion release. In
the following, we discuss components and functions of the.
Figure 1. ESCRT Pathway Recruitment
Cellular and viral adaptor proteins and complexes that recruit early-acting ESCRT factors and NEDD4 family ubiquitin E3 ligases to different sites of ESCRT-
dependent membrane fission are depicted schematically. The figure emphasizes how different retroviruses hijack the ESCRT pathway using late assembly
domains within their Gag polyproteins (yellow background, Gag proteins in orange, with their constituent domains shown schematically) and how these in-
teractions mimic analogous interactions between cellular adaptors (underlined) and ESCRT factors (white background). Polyubiquitin chains are depicted as
connected yellow hexagons, solid arrows denote known protein-protein interactions, dashed arrows denote inferred or indirect protein-protein interactions, and
question marks indicate that the site(s) of ubiquitin attachment are uncertain (see text). HIV, human immunodeficiency virus; RSV, Rous sarcoma virus; EIAV,
equine infectious anemia virus; MVB, multivesicular body; ART, arrestin-related trafficking adaptor. For illustration purposes, we selected retroviruses that bud
primarily through P(T/S)AP (HIV-1), PPXY (RSV), and YPXL (EIAV) late assembly domains, but note that these viruses all also use auxiliary late assembly domains,
including an YPXL motif in RSV (not shown) (Dilley et al., 2010).
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and outline important next steps for future research.
The ESCRT Pathway
ESCRT Pathway Functions
The ESCRT pathway was initially identified through genetic ana-
lyses in yeast that defined the factors required to target mem-
brane proteins for degradation within vacuoles (or lysosomes
in mammalian cells) (Hanson and Cashikar, 2012; Henne et al.,
2011). Such ubiquitylated membrane proteins are sorted into
vesicles that bud inward into the lumen of maturing endosomes
or multivesicular bodies (MVB) and are then degraded when the
MVB fuses with the vacuole. As illustrated in Figure 1, the MVBCevesiculation/trafficking pathway is expanded in mammalian cells
because MVBs can either fuse with lysosomes to release vesicle
contents for degradation or fuse with the plasma membrane to
release extracellular exosomes (Akers et al., 2013; Raposo and
Stoorvogel, 2013).
Since the initial discovery that HIV-1 usurps the ESCRT
pathway to bud from the plasma membrane (Demirov et al.,
2002; Garrus et al., 2001; Martin-Serrano et al., 2001; Patnaik
et al., 2000; VerPlank et al., 2001), many other enveloped viruses
have been shown to utilize this pathway (Table S1). Moreover,
even in uninfected cells, vesicles can bud directly from the
plasma membrane (termed shedding microvesicles or ecto-
somes) (Akers et al., 2013; Nabhan et al., 2012). These differentll Host & Microbe 14, September 11, 2013 ª2013 Elsevier Inc. 233
Cell Host & Microbe
ReviewESCRT-dependent processes share the same reverse topology
and produce small vesicles of similar sizes (30–120 nm), but
differ in the target membrane from which vesiculation occurs
(endosome versus plasmamembrane), the site of vesicle release
(lysosome versus extracellular space), and/or the cargo (mem-
brane proteins versus exosomal cargoes versus viral genomes).
In 2007, Martin-Serrano and colleagues demonstrated that the
ESCRT pathway also severs the thin intercellular bridges that
connect daughter cells during the final step of cell division
(termed abscission) (Agromayor andMartin-Serrano, 2013; Carl-
ton and Martin-Serrano, 2007; Fededa and Gerlich, 2012). This
unexpected discovery emerged from their work on HIV budding
and beautifully illustrates how analyses of host-microbe inter-
actions can illuminate important cell biology (and vice versa).
Abscission appears to have been the primordial ESCRT pathway
function because crenarchaeal organisms that lack internal
membranes nevertheless use a primitive ESCRT pathway to
divide (Samson and Bell, 2009). During abscission, the ESCRT
pathway againmediates membrane fission from the cytoplasmic
face of the intercellular bridge, but the membrane must be con-
stricted over a much larger distance, starting from a diameter of
1 mm inmammalian cells. Moreover, ESCRT pathway functions
must be integrated with other complex mitotic processes,
including cleavage furrow ingression, microtubule severing,
chromosome segregation, and the abscission checkpoint (Agro-
mayor and Martin-Serrano, 2013; Fededa and Gerlich, 2012;
McCullough et al., 2013). The complexity of cytokinesis, together
with the variety of different ESCRT pathway functions, seems to
explain why the mammalian ESCRT pathway has more than 30
components, including multiple isoforms of nearly all core
ESCRT factors.
ESCRT Pathway Components
Although the ESCRT pathway functions as an integrated mem-
brane fission machinery, three broad classes of factors are re-
cruited sequentially to perform distinct functions: (1) adaptor
proteins define sites of ESCRT action at specific membranes
(Figure 1), (2) early-acting factors initiate ESCRT assembly and
stabilize membrane curvature, and (3) late-acting factors
mediate membrane constriction and fission. Examples of the
growing list of ESCRT adaptors include HRS/STAM (MVB vesi-
cles); viral structural proteins such as retroviral Gag proteins,
arenaviral Z proteins, and filoviral VP40 proteins (viruses);
CEP55 (abscission); ARRDC1 (shedding microvesicles); and
Syntenin/Syndecan (exosomes) (Figure 1). These adaptors
localize to different membranes and membrane domains—often
by recognizing specific phospholipids—where they concentrate
vesicle cargoes and recruit the early-acting ESCRT factors. Two
different classes of early-acting ESCRT factors have been iden-
tified: Bro1 domain proteins and ESCRT-I/ESCRT-II complexes.
Although distinct in architecture, these factors share several key
mechanistic activities, including the ability to bind ubiquitin and
recruit late-acting ESCRT-III subunits. ESCRT-III subunits then
form filaments and recruit VPS4 ATPases, which together
constrict membranes and mediate fission. The following sec-
tions summarize the structures and functions of core early-
and late-acting ESCRT factors. We refer readers to other recent
reviews for more comprehensive descriptions of the ESCRTma-
chinery and full primary references (Agromayor and Martin-
Serrano, 2013; Hanson and Cashikar, 2012; Henne et al., 2011;234 Cell Host & Microbe 14, September 11, 2013 ª2013 Elsevier IncHurley and Hanson, 2010; McCullough et al., 2013; Weissenhorn
et al., 2013).
Bro1 Domain Proteins. ALIX is the founding member of a family
of related Bro1 domain-containing mammalian proteins that also
include HD-PTP, BROX, RHPN1, and RHPN2. ALIX is recruited
by many viral structural proteins (Strack et al., 2003 and Table
S1) and also by CEP55 during cytokinesis (Carlton and Martin-
Serrano, 2007) and by Syndecan/Syntenin during exosome for-
mation (Baietti et al., 2012). These observations imply that ALIX
can initiate ESCRT assembly. Recently, the yeast Bro1p homo-
log was shown to act early in the yeast MVB pathway, indicating
that Bro1p is likely a true ALIX homolog (Pashkova et al., 2013).
Bro1 domains bind and recruit downstream ESCRT-III subunits
of the CHMP4/Snf7p and CHMP5 families. ALIX Bro1 also can
bind membranes, particularly lysobisphosphatidic acid (LBPA)
(Bissig et al., 2013), and may help stabilize (or drive) membrane
curvature at bud necks, owing to its crescent shape (Kim et al.,
2005; Pires et al., 2009). The activities of different Bro1 family
members can be modulated by a series of auxiliary domains
and inputs, including (1) calcium and calcium-responsive binding
partners (ALIX) (Bissig et al., 2013; Okumura et al., 2013), (2)
downstream V domains (in ALIX/Bro1p and HD-PTP) that can
bind both ubiquitin (Dowlatshahi et al., 2012; Keren-Kaplan
et al., 2013; Pashkova et al., 2013) and YPXL motifs (see below),
(3) autoinhibitory elements and their activating partners (ALIX)
(Zhai et al., 2011a; Zhou et al., 2010), and (4) posttranslational
modifications such as ubiquitylation (ALIX) and farnesylation
(BROX).
ESCRT-I/ESCRT-II. Mammals express a variety of heterotetra-
meric ESCRT-I complexes, each of which contains a single copy
of the unique TSG101 subunit and single copies of one of the
different isoforms of VPS28, VPS37, and MVB12/UBAP1
(McCullough et al., 2013). ESCRT-I, in turn, can bind the hetero-
tetrameric ESCRT-II complex, which contains single copies of
EAP45 and EAP30, and two copies of EAP20. The large, cres-
cent-shaped ESCRT-I/ESCRT-II supercomplex concentrates
within the necks of budding vesicles (Boura et al., 2012; Hurley
and Hanson, 2010; Wollert and Hurley, 2010) and contains a
series of accessory domains and motifs that can bind adaptors,
ubiquitin, membranes, and specific phosphatidyl inositides
(Henne et al., 2011; Hurley and Hanson, 2010; McCullough
et al., 2013). The two EAP20 subunits of ESCRT-II bind the
ESCRT-III protein, CHMP6 (Im et al., 2009), which in turn binds
CHMP4 (ESCRT-III) (Carlson and Hurley, 2012; Henne et al.,
2012). Thus, both ALIX and ESCRT-I/ESCRT-II ultimately func-
tion to recruit CHMP4 and promote ESCRT-III filament formation
within the bud neck.
ESCRT-III Proteins. Mammals have twelve different ESCRT-III
subunits that comprise eight subfamilies, designated CHMP1–
7, and IST1, with three isoforms of CHMP4 (designated A–C)
and two isoforms each of CHMP1 and CHMP2. The ESCRT-III
core is an unusual four-helix bundle in which the first two helices
form a long antiparallel hairpin and the two shorter helices pack
against the open end of the hairpin (Henne et al., 2011; Hurley
and Hanson, 2010; McCullough et al., 2013). C-terminal tails of
variable length and sequence fold back on the ESCRT-III core
and function as autoinhibitory elements. When autoinhibition is
relieved, ESCRT-III proteins can form homo- and hetero-oligo-
meric filaments that can further assemble into helices, both.
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shown to associate tightly withmembranes and induce extrusion
of membrane tubules from the plasma membrane (Bodon et al.,
2011; Effantin et al., 2013; Hanson et al., 2008), indicating that
ESCRT-III proteins likely also form helices or spirals within bud
necks. The different ESCRT-III subunits engage in a hierarchy
of protein-protein interactions in which their different core
domains make preferential pairwise interactions (Babst et al.,
2002; Carlson and Hurley, 2012), while their C-terminal tails
bind VPS4 ATPases and other binding partners, particularly dur-
ing abscission. The structures of ESCRT-III filaments are not well
understood, but 3–4 nm filaments are common, and paired
CHMP4 filaments can form in vitro, consistent with the observa-
tion that each nucleating ESCRT-II complex contains two copies
of the EAP20 ESCRT-III binding subunit (Henne et al., 2012).
Similarly, ALIX can also dimerize and crosslink CHMP4 filaments
(Pires et al., 2009), although the functional purpose (if any) of
paired filament formation is not known.
VPS4 ATPases. As the only known enzymes in the ESCRT
pathway, VPS4 ATPases power the pathway by converting the
energy of ATP hydrolysis into mechanical work. Mammals
express two closely related VPS4 proteins (A and B), whose
functions are interchangeable, at least in some contexts. Like
other AAA ATPases, VPS4 proteins function as hexameric rings
whose assembly and ATPase activities are regulated by other
ESCRT factors, particularly the stimulatory LIP5 cofactor (Hill
and Babst, 2012). VPS4 enzymes use an unusual N-terminal
three-helix bundle, termed the MIT domain, to bind several
different types of motifs within the exposed C-terminal tails of
polymerized ESCRT-III substrates (Hill and Babst, 2012; McCul-
lough et al., 2013). ESCRT-III subunits are then apparently
‘‘pulled’’ up into the central pore of the hexameric ring in an
ATP-dependent manner (Hill and Babst, 2012), and this activity
can depolymerize ESCRT-III filaments in vitro (Lata et al.,
2008). ESCRT-III subunits are thereby released for multiple
rounds of MVB vesicle formation, and there is some evidence
that VPS4 remodeling of ESCRT-III filaments also may be
required for membrane fission (Baumga¨rtel et al., 2011; Elia
et al., 2011; Jouvenet et al., 2011).
Models for Membrane Fission. A key unanswered question is
how ESCRT-III filaments can drive membrane constriction and
fission (Hanson and Cashikar, 2012; Henne et al., 2011; McCul-
lough et al., 2013). Although a consensus has not been reached,
mechanistic models envision that ESCRT-III filaments could
form tapering spirals or whorls that pull the opposing mem-
branes toward a central fission point (e.g., the ‘‘dome’’ [Fabrikant
et al., 2009], ‘‘whorl’’ [Boura et al., 2012], and ‘‘hourglass’’ [Dobro
et al., 2013] models) and/or that spiraling filaments could
constrict membranes by sliding past themselves, perhaps with
the assistance of VPS4 (e.g., the ‘‘break and slide’’ [Elia et al.,
2011] and ‘‘purse string’’ [Saksena et al., 2009] models).
Lessons from Virology
Our understanding of ESCRT pathway functions and mecha-
nisms has benefited greatly from the interplay between studies
of cell biology and virology. Viral systems offer a series of useful
experimental features, including (1) ease of genetic manipulation
and powerful experimental readouts, such as virion release and
infectivity, and (2) plasma membrane assembly, which is partic-Ceularly amenable for imaging studies. Furthermore, viruses may
highlight essential core ESCRT activities because they appear
to utilize a streamlined machinery that bypasses the elaborate
regulatory controls required by cellular processes.
Viral Recruitment of the ESCRT Pathway
Virus budding is usually coupled tightly to virion assembly, and
most viruses therefore use their structural proteins to recruit
the ESCRT pathway. The first indication that virus budding might
be mediated by host factors came from the work of Go¨ttlinger
and colleagues, who showed that the p6 region of the HIV-1
Gag polyprotein, though not required for Gag polymerization,
is required to detach the nascent virions from the plasma
membrane (Go¨ttlinger et al., 1991). Subsequent studies identi-
fied two different short peptide motifs within p6Gag that contrib-
uted to the efficiency of HIV-1 budding (Go¨ttlinger et al., 1991;
Huang et al., 1995; Strack et al., 2003). In parallel, others identi-
fied distinct short peptide motifs within the structural proteins of
other viruses and called these motifs ‘‘late assembly domains’’
because their mutation typically arrested virus assembly at a
very late stage (Parent et al., 1995; Puffer et al., 1997). We now
understand that different enveloped viruses use at least five
distinct classes of late assembly domains, which can often func-
tion interchangeably. In several instances, the discovery of new
viral late assembly domains has subsequently led to the identifi-
cation of analogous motifs within cellular proteins that bind and
recruit ESCRT factors, implying that the late assembly domains
act by mimicking comparable cellular interactions (Figure 1 and
Table S1).
P(T/S)AP Late Assembly Domains Bind the TSG101 Subunit of
ESCRT-I. The tetrapeptide late assembly domain motif
P(T/S)AP (where the second amino acid can either be a Thr or
a Ser) was first identified within HIV-1 p6Gag (Go¨ttlinger et al.,
1991; Huang et al., 1995) and was subsequently found within
the structural proteins of filoviruses, arenaviruses, rhabdovi-
ruses, and reoviruses (see Table S1 for a full, referenced list).
The P(T/S)AP late assembly domain functions by binding directly
to the UEV domain of TSG101, thereby recruiting ESCRT-I to
virus assembly sites (Demirov et al., 2002; Garrus et al., 2001;
Martin-Serrano et al., 2001; VerPlank et al., 2001). UEV domains
are structurally related to ubiquitin E2 conjugating enzymes,
but lack the active-site cysteine required for ubiquitin transfer.
The P(T/S)AP peptides bind in a groove of the TSG101 UEV
domain, which, in functional E2 enzymes, is normally occluded
by two terminal helices. Each of the four P(T/S)AP residues
makes specific contacts within the UEV groove, which explains
the high conservation of this late assembly domain sequence
(Im et al., 2010).
P(T/S)AP motifs were subsequently identified in a series of
cellular proteins that act as adaptors that recruit ESCRT pathway
components, including the endosomal adaptors HRS/STAM,
GGA3, and TOM1L1 (Hanson and Cashikar, 2012; McCullough
et al., 2013) and the plasma membrane shedding microvesicle
adaptor, ARRDC1 (Nabhan et al., 2012). P(T/S)AP motifs are
also present in some membrane proteins, such as Gap-junction
proteins, that appear to be downregulated through the ESCRT
pathway (Gaietta et al., 2002).
YPXL Late Assembly Domains Bind ALIX. The YPXL late as-
sembly domain was initially identified when it was shown that
the p9Gag YPDL tetrapeptide is required for budding of thell Host & Microbe 14, September 11, 2013 ª2013 Elsevier Inc. 235
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1997). YPXL late assembly domains function by binding directly
to the central V-domain of ALIX (Fisher et al., 2007; Lee et al.,
2007; Strack et al., 2003; Usami et al., 2007; Zhai et al., 2008,
2011b). YPXL late assembly domains have since been identified
in other retroviruses, including HIV-1 and murine leukemia virus
(MLV), and ALIX now is known to facilitate release of paramyxo-
viruses, arenaviruses, flaviviruses, hepadnaviruses, herpesvi-
ruses, and tombusviruses (Table S1).
Structural studies revealed that the ALIX binding motif is best
described by the complex consensus sequence: FYX0/2(P/F)
X0/3(L/I), where F denotes a hydrophobic residue and X denotes
amino acid spacers of different lengths (Zhai et al., 2008, 2011b).
The anchoring tyrosine residue binds in a pocket in the second
arm of the ALIX V domain, and the flanking hydrophobic residues
bind in shallower pockets on the surface of arm 2. Remarkably,
the variability in spacing between the conserved hydrophobic
residues is accommodated by different intervening secondary
structures, with extended, strand-like conformations used to
span short spacers and a helices used to span longer spacers.
The discoveries of ALIX-YPXL interactions in viruses and in
PalA, which is a component of the ESCRT-dependent pH
sensing system in Aspergillus (Vincent et al., 2003), contributed
to the subsequent identification of analogous ALIX-recruiting
motifs in other cellular proteins, which include theMVB/exosome
adaptor, Syndecan/Syntenin (Baietti et al., 2012), as well as sub-
strates of the MVB pathway, such as PAR1, a mammalian G pro-
tein-coupled receptor that is downregulated through the MVB
pathway following activation (Dores et al., 2012).
PPXY Late Assembly Domains Bind NEDD4 Family Proteins.
The PPXY late assembly domain motif (where X can be any
amino acid but is most commonly proline) was first identified
within the p2bGag region of Rous sarcoma virus (Figure 1) (Parent
et al., 1995). PPXY late assembly domains also are present in a
wide range of other retroviruses, as well as in rhabdoviruses,
filoviruses, arenaviruses, reoviruses, and hepadnaviruses (Table
S1). Thesemotifs function by binding theWWdomains present in
members of the NEDD4 family of HECT ubiquitin E3 ligases (Gar-
nier et al., 1996; Macias et al., 2002). WW domains are three-
stranded, antiparallel b sheets, and the PPXY motif binds in a
shallow groove on one side of the sheet. The first two prolines
dock between conserved aromatic residues of the WW domain,
and the tyrosine contacts residues from the second and third
strands (Macias et al., 2002).
PPXY motifs were initially identified in cellular proteins that are
binding partners and often ubiquitylation substrates of NEDD4
family members that are sorted through the MVB pathway (Rotin
and Kumar, 2009). Ubiquitin transfer is also important for NEDD4
family-dependent virus budding (Chung et al., 2008; Martin-
Serrano et al., 2005; Spidel et al., 2004; Usami et al., 2008;Weiss
et al., 2010; Zhadina et al., 2007). The relevant substrates, ubiq-
uitin sensor(s), and protein-protein interactions that connect
NEDD4 family members and their substrates to the ESCRT
pathway are not well understood, but there is evidence
that arrestin-related trafficking adaptors (ARTs, especially
ARRDC1-4) participate (Rauch and Martin-Serrano, 2011). This
observation is consistent with known connections between
ARTs, ESCRT factors, and the sole yeast NEDD4 homolog,
Rsp5p (Lin et al., 2008) and with the observation that ARRDC1236 Cell Host & Microbe 14, September 11, 2013 ª2013 Elsevier Incalso recruits NEDD4 family E3 ligases and ESCRT factors to
release shedding vesicles from the plasma membrane (Figure 1)
(Nabhan et al., 2012).
Ubiquitin-Dependent Recruitment of the ESCRT Pathway.
Retroviral virions concentrate ubiquitin (Putterman et al., 1990),
and ubiquitin appears to function at the budding step because
(1) ubiquitin depletion inhibits virus budding (Patnaik et al.,
2000; Schubert et al., 2000; Strack et al., 2000); (2)
ubiquitin can sometimes function as a late assembly domain
when fused directly to retroviral Gag proteins (Joshi et al.,
2008; Patnaik et al., 2000); (3) the known early-acting mamma-
lian ESCRT factors ALIX, ESCRT-I, and ESCRT-II all contain
ubiquitin-binding domains (UBDs); and (4) genetic analyses indi-
cate that ALIX binding to K63-linked ubiquitin chains enhances
EIAV and HIV-1 budding (Dowlatshahi et al., 2012; Keren-Kaplan
et al., 2013). In most cases, however, the key ubiquitin sensor(s)
have not been identified, perhaps because ESCRT pathway
UBDs function redundantly. Similarly, the functional target(s) of
ubiquitylation have not been defined unambiguously, although
the viral structural proteins themselves are leading candidates
(Sette et al., 2013; Weiss et al., 2010), and budding efficiency
correlates with formation of K63-linked polyubiquitin chains on
HIV-1 Gag (Weiss et al., 2010). Thus, ESCRT recruitment by viral
structural proteins may be analogous to ESCRT recruitment by
mono- and K63-linked polyubiquitylated membrane proteins
that are sorted into MVB vesicles (Shields and Piper,
2011). However, ubiquitin-dependent budding of the retrovirus
prototypic foamy virus does not require Gag ubiquitylation
(Zhadina et al., 2007). In this and perhaps other cases, ubi-
quitylation of the ESCRT machinery itself may play a key func-
tional role.
Additional Late Assembly Domains and Partners. A series of
observations indicate that additional late assembly domains
and/or their ESCRT binding partners remain to be identified
and characterized: (1) ‘‘FPIV’’ late assembly domains (consensus
sequence ØPxV, where Ø is an aromatic residue) within the M
proteins of the paramyxoviruses human parainfluenzavirus type
5 (hPIV-5) and mumps virus stimulate ESCRT-dependent virus
budding (Li et al., 2009; Schmitt et al., 2005); (2) AMOTL1 can
also bind hPIV-5 M and facilitate virus release (Pei et al., 2010);
(3) a-taxilin is required for efficient release of hepatitis B (a
hepadnavirus) and can associate with TSG101 (Hoffmann
et al., 2013); (4) isolated Bro1 domains and Bro1 family members
that lack YPXL binding activities can interact with retroviral
NCGag domains (Bello et al., 2012; Dussupt et al., 2009; Popov
et al., 2008, 2009); (5) in several cases, NEDD4 family members
can stimulate release of retroviral Gag proteins that lack PPXY
late assembly domains, implying novel interaction modes (Calis-
tri et al., 2009; Chung et al., 2008; Jadwin et al., 2010; Usami
et al., 2008; Weiss et al., 2010). This phenomenon is best char-
acterized for HIV-1, where overexpression of NEDD4L can
‘‘rescue’’ the release and infectivity of viral constructs that lack
TSG101 and ALIX binding sites (Chung et al., 2008; Usami
et al., 2008;Weiss et al., 2010). This activity requires the NEDD4L
ubiquitin E3 ligase activity and is not observed for other NEDD4
family members, implying specific connections between
NEDD4L and the assembling virion, and (6) the actin remodeling
protein IQGAP is required for efficient release of Ebola virus-like
particles (Lu et al., 2013). IQGAP also can bind the structural.
Figure 2. Multiple Late Assembly Domains of HIV-1 Gag Recruit Different ESCRT-Associated Factors that May Work Together to Facilitate
Virus Budding
The model suggests how three different early-acting ESCRT-associated factors recruited by HIV-1 Gag—NEDD4L (pink), ESCRT-I (red), and dimeric ALIX (dark
blue)—could work together in a stepwise fashion to facilitate virus budding. The three regions of HIV-1 Gag are depicted in yellow (MA), orange (CA), and red (NC,
bound to blue RNA); the subunits of the trimeric viral Env protein are depicted in blue (SU/gp120) and pink (TM/gp41); and ESCRT-III proteins (light green) are
depicted schematically as either polymeric filaments (central panel, light green ring) or soluble, autoinhibited subunits (right panel, discrete subunits). ESCRT-I is
missing from the final panel because the ultimate fate of this complex is not yet clear.
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2006; Lu et al., 2013; Morita et al., 2007), although the functional
relevance of these interactions remains to be established.
Viruses Frequently Use Multiple Late Assembly Domains. Most
ESCRT-dependent viruses appear to enter the ESCRT pathway
using multiple late assembly domains and binding partners
(Table S1). For example, HIV-1 recruits three different ESCRT-
associated factors: TSG101/ESCRT-I, ALIX, and NEDD4L. The
use of multiple late assembly domains may help extend viral
tropism. For example, HIV-1 p6Gag P(T/S)AP-TSG101 is the
dominant interaction for viral budding from transformed epithe-
lial cell lines, but the p6Gag YPXL-ALIX interaction apparently
can play a more important role in some T cells (Fujii et al.,
2009). Different late assembly domain partners may also work
together to provide temporal control or complementary budding
activities. As illustrated in Figure 2, one possibility is that HIV-1
could initially engage NEDD4L to induce Gag ubiquitylation,
which in turn could allow high-affinity binding of TSG101 and
ALIX because both of these early-acting factors can bind both
HIV-1 Gag and ubiquitin, and they can also bind one another.
Thus, although late assembly domains and their ESCRT binding
partners are often studied in isolation, they actually may form
dynamic supercomplexes whose multiple components work
together to orchestrate the stepwise transformations necessary
to terminate virus assembly and initiate ESCRT factor recruit-
ment and activation.
Late-Acting ESCRT Factors and Virus Budding
The late-acting ESCRT-III and VPS4 factors are recruited to viral
budding sites immediately prior to virion release (Baumga¨rtel
et al., 2011; Jouvenet et al., 2011) and appear to catalyze mem-
brane constriction and fission. Although the roles of the manyCedifferent ESCRT-III proteins remain to be characterized in detail,
siRNA depletion experiments indicate that of the eight different
human ESCRT-III protein families, only CHMP4 and CHMP2
family members are absolutely critical for HIV and EIAV budding
(Morita et al., 2011; V. Sandrin and W.I.S., unpublished data).
Modest effects on HIV-1 budding were also seen upon depletion
of CHMP1 and CHMP3 proteins, and there are other indications
that both of these ESCRT-III families may participate in HIV-1
release (Carlson and Hurley, 2012; Effantin et al., 2013; Jouvenet
et al., 2011). EIAV is the best-understood and most streamlined
model system for ESCRT-mediated membrane fission because,
unlike HIV-1, EIAV virus does not use ESCRT-I. Instead, the sole
YPDL late assembly domain in Gag recruits ESCRT factors
through a set of ordered, direct protein-protein interactions:
Gag:ALIX:CHMP4:CHMP2:VPS4 (Figure 1) (V. Sandrin and
W.I.S., unpublished data). Structural models are available for
each of these protein-protein interactions, with the exception
of the CHMP4:CHMP2 interaction, which is not well understood.
In addition to their uniquely critical roles in HIV-1 and EIAV
budding, there are several other indications that the CHMP4
and CHMP2 families play especially fundamental roles in mem-
brane deformation and scission. For example, several simple
eukaryotes like P. falciparum and E. histolytica have apparent
CHMP4 and CHMP2 homologs, but lack other core ESCRT-III
homologs (Leung et al., 2008). Furthermore, both CHMP2 and
CHMP4 proteins can extrude helical tubes from the plasma
membrane when overexpressed (Bodon et al., 2011; Hanson
et al., 2008), whereas this activity has not been reported for other
ESCRT-III proteins. CHMP4 subunits appear to constitute the
major building block of ESCRT-III filaments (Teis et al., 2008)
that may be capped (or copolymerize) with CHMP2, which inll Host & Microbe 14, September 11, 2013 ª2013 Elsevier Inc. 237
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Reviewturn recruits VPS4. CHMP3 may help to stabilize or bridge
CHMP2-CHMP4 interactions, particularly for the CHMP2A iso-
form (Carlson and Hurley, 2012; Effantin et al., 2013), and
CHMP1may arrive late and contribute to VPS4 recruitment (Carl-
son and Hurley, 2012).
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Although viruses have contributed substantially to our under-
standing of ESCRT pathway recruitment and function, important
gaps in our knowledge remain to be filled. As discussed above,
several late assembly domains and partners remain to be identi-
fied; the complete sequence of ESCRT protein-protein interac-
tions required for viral budding through the P(T/S)AP, PPXY,
and FPIV late assembly domains remains to be determined;
the role(s) of ubiquitin remain to be defined; and models for
ESCRT-III filament structure and function need to be tested.
Furthermore, although the membrane lipid compositions of
several enveloped viruses are known, the role(s) of the lipid in
virus budding are not well understood (Lorizate and Kra¨usslich,
2011). Finally, it also will be important to determine the functions
and ESCRT connections (if any) of the growing list of host factors
implicated in enveloped virus trafficking, assembly, and polar-
ized release and to learn how the cell monitors and controls viral
use of the ESCRT pathway (Grover et al., 2013; Kuang et al.,
2011).
ESCRT-Independent Virus Budding
Not all enveloped viruses utilize the ESCRT pathway for egress,
and the exceptions are interesting and informative (Weissenhorn
et al., 2013). ESCRT independence is typically inferred from
insensitivity to overexpression of a dominantly inhibitory VPS4
mutant that inhibits the ESCRT pathway. This is indeed strong
evidence for a lack of ESCRT pathway involvement, although
of course this conclusion will only be certain once the alternative
budding mechanism is fully understood. One important ESCRT-
independent class includes Semliki Forest virus (a togavirus)
(Taylor et al., 2007). Here, ESCRT independence is likely
explained by the robust assembly of an external membrane-
associated glycoprotein shell, which is apparently sufficient to
drive membrane deformation and fission without the assistance
of host factors (Cockburn et al., 2004; Jose et al., 2009; Taylor
et al., 2007; Weissenhorn et al., 2013).
Another intriguing example is influenza A virus (IAV, an ortho-
myxovirus), which can bind ESCRT-I but appears to be ESCRT
independent as judged by a lack of susceptibility to VPS28
depletion or VPS4 inhibition (Bruce et al., 2009). Instead, IAV ap-
pears to encode its own membrane fission machinery within the
viral M2 transmembrane protein (Rossman et al., 2010). Remark-
ably, helical amphipathic peptides corresponding to the M2 tails
exhibit membrane fission activity in vitro, and it will be important
to determine how this system works and why other viruses
instead utilize the much more elaborate ESCRT machinery.
Respiratory syncytial virus (a paramyxovirus) is also insensitive
to VPS4 inhibition (Utley et al., 2008), and respiratory syncytial
virus, IAV (Bruce et al., 2010), and Andes virus (a bunyavirus)
(Rowe et al., 2008) all require a functional Rab11 pathway for
release. Rab11 depletion causes extruded respiratory syncytial
virus and IAV virions to accumulate at the plasma membrane,
implying a budding defect. However, Rab11 typically functions238 Cell Host & Microbe 14, September 11, 2013 ª2013 Elsevier Incin vesicle targeting and fusion at recycling endosomes, so it
remains unclear whether Rab11 is required for proper trafficking
of viral or cellular factors or participates directly in viral mem-
brane budding/fission reactions (and if so, how).
Nonenveloped Viruses and Exosome Cargoes
Unlike enveloped viruses, nonenveloped viruses are typically
released by cell lysis. However, ‘‘nonenveloped’’ viruses such
as Bluetongue (a reovirus) and hepatitis A (a picornavirus) can
also recruit the ESCRT pathway and be released within mem-
branes (Feng et al., 2013; Wirblich et al., 2006). Moreover, the
viral RNAs from cells infected with hepatitis C (a flavivirus) can
be released within exosomes and subsequently trigger immune
responses within nonpermissive plasmacytoid dendritic cells
and establish infection (Dreux et al., 2012; Ramakrishnaiah
et al., 2013). These phenomena have important implications for
immune recognition and evasion and blur the distinctions be-
tween enveloped and nonenveloped viruses and exosomes
(Gould et al., 2003).
ESCRT Requirements for Virus Entry
In addition to their importance in viral egress, ESCRT factors are
also required for the entry of some rhabdoviruses, arenaviruses,
flaviviruses, and baculoviruses (see Table S1). These viruses
enter cells via receptor-mediated endocytosis and are then
released into the cytoplasm when they cross the limiting mem-
brane of the late endosome. Their ESCRT dependence remains
to be understood in mechanistic detail, but it is difficult to envi-
sion how the canonical membrane fission activity of the ESCRT
pathway could contribute directly to membrane fusion. One
intriguing alternative is that these viruses may fuse with intralu-
menal MVB vesicles (whose formation is ESCRT dependent)
and are then released into cytoplasm when the intralumenal ves-
icles backfuse with the limiting endosomal membrane (Le Blanc
et al., 2005). It will therefore be critical to document and charac-
terize this unusual backfusion reaction, which also has important
implications for intercellular sharing of exosomal cargoes.
Summary
To spread infection, viruses must cross cellular membranes
efficiently, and both entry and budding require complex interac-
tions between host and viral factors. A key difference, however,
is that while most enveloped viruses encode their own mem-
brane fusion proteins to mediate entry, many viruses instead
harness the cellular ESCRT machinery to effect membrane
fission during egress. Relentless selective pressure has led en-
veloped viruses to mimic the remarkable variety of different
cellular ESCRT recruitment mechanisms, and studies of virus
budding will continue to inform ESCRT pathway functions in
cellular vesiculation and abscission and shed light on the contin-
uum between biogenesis of viruses and extracellular vesicles.
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